Drug Manufacturers—Specialty & Generic

Organigram Holdings Inc (NASDAQ: OGI) Q3 2023 earnings call dated Jul. 14, 2023 Corporate Participants: Max Schwartz -- Director of Investor Relations…

Strides Pharma Science Limited ( ?????? : STAR) Q4 2023 Earnings Con Call dated May. 25, 2023 Corporate participants: Arun…

CRESCO LABS INC-SUBORDINATE (PNK : CL) Q1 2023 Earnings Call dated May. 24, 2023. Corporate Participants: Megan Kulick -- Senior…

AbbVie (NYSE: ABBV) Q1 2023 Earnings Call dated Apr. 27, 2023 Corporate Participants: Elizabeth Shea -- Senior Vice President of…

Organigram Holdings, Inc. (NASDAQ: OGI) Q2 2023 earnings call dated Apr. 12, 2023 Corporate Participants: Max Schwartz -- Director of Investor Relations…

Aurora Cannabis Inc.  (NYSE: ACB) Q3 2022 earnings call dated May. 12, 2022 Corporate Participants: Ananth Krishnan -- Vice President, Corporate Development…

Perrigo Coompany PLC  (NYSE: PRGO) Q1 2022 earnings call dated May. 11, 2022 Corporate Participants: Bradley Joseph -- Vice President, Global Investor…

Cronos Group Inc.  (NASDAQ: CRON) Q1 2022 earnings call dated May. 10, 2022 Corporate Participants: Shayne J. Laidlaw -- Director of Investor…

ANI Pharmaceuticals Inc.  (NASDAQ: ANIP) Q1 2022 earnings call dated May. 10, 2022 Corporate Participants: Lisa Wilson -- Investor Relations Nikhil Lalwani -- President…

PetIQ Inc.  (NASDAQ: PETQ) Q1 2022 earnings call dated May. 04, 2022 Corporate Participants: Katie Turner -- Investor Relations McCord Christensen -- Chief Executive…

PetIQ, Inc.  (NASDAQ: PETQ) Q4 2021 earnings call dated Mar. 01, 2022 Corporate Participants: Katie Turner -- Investor Relations McCord Christensen -- Chief Executive…

Cronos Group Inc.  (NASDAQ: CRON) Q4 2021 earnings call dated Mar. 01, 2022 Corporate Participants: Shayne Laidlaw -- Investor Relations Kurt T.…

Aurora Cannabis Inc.  (NYSE: ACB) Q2 2022 earnings call dated Feb. 10, 2022 Corporate Participants: Ananth Krishnan -- Vice President- Strategic Finance…

Tilray, inc  (NASDAQ: TLRY) Q2 2022 earnings call dated Jan. 10, 2022 Corporate Participants: Berrin Noorata -- Chief Corporate Affairs Officer Irwin…

Merck & Co., Inc. (NYSE: MRK) Q3 2021 earnings call dated Oct. 28, 2021 Corporate Participants: Peter Dannenbaum -- Vice President, Investor…

Cipher Pharmaceuticals Inc.  (TSX: CPH) Q4 2020 earnings call dated Mar. 19, 2021 Corporate Participants: Craig Mull -- Interim Chief Executive Officer…

HEXO Corp.  (NYSE: HEXO) Q2 2021 earnings call dated Mar. 18, 2021 Corporate Participants: Sebastien St-Louis -- Co-founder and Chief Executive Officer…